NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-05d361
Description
Project title: NHS National Framework for Transition Products (Nintedanib and Dalbavancin) commencing 1st May 2026
Offer reference number: CM/TNS/25/5736
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/25/5736 Nintedanib and Dalbavancin
Lot 1 DLN/DNW: 01/05/2026 to 30/09/2027 (17 months)
Lot 2 DLS/DNE: 01/05/2026 to 31/05/2027 (13 months)
Lot 3 DCE/DSW: 01/05/2026 to 31/01/2027 (9 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Notices
UK4: Tender notice
- Notice identifier
- 2025/S 000-084554
- Published
- 18 December 2025, 3:49pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-068187
- Published
- 24 October 2025, 12:45pm